|
⚲
|
| Keyboard |
| Olwill Shane
✚
|
|
|---|---|
| CIK # | 0001875416 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001875416] | |
| 4 | [0001875416] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Palvella Therapeutics Inc | |
| Olwill Shane |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Palvella Therapeutics Inc PIRS
Stock Option (Right to buy) · derivative
|
2023-02-24 | Grant | 249,080 | $0.00 | |
|
Palvella Therapeutics Inc PIRS
Stock Option (Right to buy) · derivative
|
2022-02-22 | Grant | 215,819 | $0.00 | |
|
Palvella Therapeutics Inc PIRS
Common Stock
|
2021-08-30 | Option exercise | 38,400 | $1.52 | 58,368 |
|
Palvella Therapeutics Inc PIRS
Common Stock
|
2021-08-30 | Sell | 29,200 | $5.15 | 150,380 |
|
Palvella Therapeutics Inc PIRS
Common Stock
|
2021-08-30 | Sell | 9,200 | $5.00 | 46,000 |
|
Palvella Therapeutics Inc PIRS
Stock Option (right to buy) · derivative
|
2021-08-30 | Option exercise | 38,400 | $0.00 |